Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Parasite Elimination in the Human and Mosquito to Reduce Malaria Transmission: A Cluster Randomised Controlled Factorial Design Trial of Reactive Focal Drug Administration (rfMDA) Versus Reactive Case Detection (RACD), With and Without Reactive Vector Control (RAVC), From the Low Endemic Setting of Namibia

NCT02610400 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02610400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02610400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Parasite Elimination in the Human and Mosquito to Reduce Malaria Transmission: A Cluster Randomised Controlled Factorial Design Trial of Reactive Focal Drug Administration (rfMDA) Versus Reactive Case Detection (RACD), With and Without Reactive Vector Control (RAVC), From the Low Endemic Setting of Namibia
Lead sponsor
University of California, San Francisco
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2016
Completion date
December 31, 2017
Enrollment
9,845 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria